UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 71,795 Shares of Zions Bancorporation, National Association (NASDAQ:ZION)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Zions Bancorporation, National Association (NASDAQ:ZION - Free Report) by 16.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 502,201 shares of the bank's stock after buying an additional 71,795 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.34% of Zions Bancorporation, National Association worth $27,244,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. EverSource Wealth Advisors LLC boosted its stake in Zions Bancorporation, National Association by 51.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 541 shares of the bank's stock worth $29,000 after purchasing an additional 183 shares in the last quarter. Covestor Ltd grew its holdings in Zions Bancorporation, National Association by 128.1% during the 4th quarter. Covestor Ltd now owns 853 shares of the bank's stock worth $46,000 after acquiring an additional 479 shares during the last quarter. SRS Capital Advisors Inc. raised its stake in shares of Zions Bancorporation, National Association by 120.8% in the fourth quarter. SRS Capital Advisors Inc. now owns 901 shares of the bank's stock worth $49,000 after acquiring an additional 493 shares during the last quarter. Millstone Evans Group LLC bought a new position in shares of Zions Bancorporation, National Association in the 4th quarter valued at about $62,000. Finally, Natixis bought a new position in shares of Zions Bancorporation, National Association in the 4th quarter worth $102,000. Institutional investors and hedge funds own 76.84% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on ZION shares. Argus raised shares of Zions Bancorporation, National Association from a "hold" rating to a "buy" rating and set a $55.00 price target for the company in a research note on Monday, April 28th. Stephens cut their target price on shares of Zions Bancorporation, National Association from $54.00 to $52.00 and set an "equal weight" rating on the stock in a research report on Tuesday, April 22nd. Truist Financial began coverage on Zions Bancorporation, National Association in a research note on Tuesday, May 13th. They issued a "hold" rating and a $52.00 target price for the company. Royal Bank of Canada dropped their price objective on Zions Bancorporation, National Association from $63.00 to $53.00 and set a "sector perform" rating on the stock in a research note on Tuesday, April 22nd. Finally, Wells Fargo & Company dropped their price objective on Zions Bancorporation, National Association from $58.00 to $47.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 22nd. Three analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $57.94.

Zions Bancorporation, National Association Trading Down 0.8%

ZION stock traded down $0.37 during midday trading on Friday, hitting $47.36. The company had a trading volume of 1,373,854 shares, compared to its average volume of 1,578,264. The stock has a market cap of $6.99 billion, a price-to-earnings ratio of 9.57, a PEG ratio of 1.61 and a beta of 0.88. Zions Bancorporation, National Association has a 52 week low of $39.32 and a 52 week high of $63.22. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.16. The stock's 50 day moving average price is $46.22 and its 200 day moving average price is $52.40.

Zions Bancorporation, National Association (NASDAQ:ZION - Get Free Report) last released its earnings results on Monday, April 21st. The bank reported $1.24 earnings per share for the quarter, topping analysts' consensus estimates of $1.20 by $0.04. The firm had revenue of $795.00 million for the quarter, compared to the consensus estimate of $792.49 million. Zions Bancorporation, National Association had a net margin of 15.70% and a return on equity of 13.65%. During the same period in the prior year, the firm earned $0.96 EPS. As a group, equities research analysts expect that Zions Bancorporation, National Association will post 5.39 earnings per share for the current fiscal year.

Zions Bancorporation, National Association Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, May 22nd. Stockholders of record on Thursday, May 15th were paid a $0.43 dividend. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 3.63%. Zions Bancorporation, National Association's dividend payout ratio (DPR) is currently 33.59%.

Zions Bancorporation, National Association declared that its Board of Directors has initiated a stock repurchase program on Monday, February 24th that permits the company to repurchase $40.00 million in outstanding shares. This repurchase authorization permits the bank to repurchase up to 0.5% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's board believes its stock is undervalued.

Zions Bancorporation, National Association Company Profile

Zions Bancorporation, National Association provides various banking products and related services primarily in the states of Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming. It operates through Zions Bank, California Bank & Trust, Amegy Bank, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and The Commerce Bank of Washington segments.